Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
11.94
-0.06 (-0.50%)
At close: Mar 9, 2026, 4:00 PM EDT
11.84
-0.10 (-0.84%)
After-hours: Mar 9, 2026, 6:12 PM EDT
Carlsmed Revenue
In the year 2025, Carlsmed had annual revenue of $50.51M with 85.94% growth. Carlsmed had revenue of $15.17M in the quarter ending December 31, 2025, with 61.19% growth.
Revenue (ttm)
$50.51M
Revenue Growth
+85.94%
P/S Ratio
6.32
Revenue / Employee
$397,724
Employees
127
Market Cap
319.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.51M | 23.35M | 85.94% |
| Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
| Dec 31, 2023 | 13.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCARL News
- 11 days ago - Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 14 days ago - Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference - GlobeNewsWire
- 19 days ago - Carlsmed Announces first corra™ personalized Cervical Plating Procedure - GlobeNewsWire
- 26 days ago - Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 27 days ago - Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure - GlobeNewsWire
- 2 months ago - Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - GlobeNewsWire
- 2 months ago - Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal - GlobeNewsWire